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A novel molecular assay for the detection and characteriza-
tion of monoclonal lymphoid populations in clinical speci-
mens was developed. The assay is based on the principle that 
upon non-denaturing polyacrylamide gel electrophoresis 
RNA molecules separate into several metastable conforma-
tional forms. These conformational polymorphisms strictly 
depend on the nucleotide sequence of the individual mole-
cule. Using DNA from formalin-fixed, paraffin-embedded 
tissue of patients with mycosis fungoides, highly variable 
junctional sequences of rearranged T-cell receptor gamma 
genes were amplified by polymerase chain reaction. Subse-
quently, the polymerase chain reactions products were tran-
scribed into complementary RNA and analyzed by non-den-
aturing polyacrylamide gel electrophoresis. In clinical 
T he detection of a monoclonal lymphoid subpopula-tion in a clinical specimen is of considerable diagnos-tic interest and suggestive of a malignant lympho-proliferative disorder. On the molecular level, mono-clonal lymphoid populations are traditionally de-
tected by Southern blot analyses ofT-cell receptor (TCR) or immu-
noglobulin gene rearrangements [1- 4]. However, in dermatology, 
Southern blot analyses are not feasible in many clinical situations, 
because relatively large amounts of well-preserved DNA are re-
quired, which are often difficult to obtain, e.g., from small skin 
biopsies or from formalin-fixed, paraffin-embedded material. In 
addition, Southern blot analyses are labor and time intensive. 
Recently, alternative approaches for the detection of clonal 
lymphoid proliferations have been reported [5,6]. These assays are 
based on the ill vitro amplification by polymerase chain reaction 
(PCR) of rearranged sequences of immunoglobulin or TCR genes. 
For example, the junctional regions of rearranged TCR-gamma 
genes differ in size and nucleotide sequence between individual 
lymphocytes. The nearly unlimited junctional variability is created 
by small deletions of n .cleotides during the process of rearrange-
ment of variable and joint segments and by insertion of random 
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specimens with a monoclonal lymphoid population, a clone-
specific pattern of bands was identified representing confor-
mational polymorphisms of cRNA molecules of rearranged 
T-cell receptor gamma genes of the predominant lymphoid 
clone. Three biopsies from one patient taken from different 
sites of the body over 3 years yielded an identical pattern of 
bands. This methodology provides a novel and rapid tool for 
the molecular identification and characterization of clonal 
lymphoid populations in clinical specimens. It is likely to be 
of special value for studies on the clonal evolution of lymph-
oid disorders of the skin. Key words: lymphoma/polymerase 
chain reaction/ clonality detection/T -cell- receptor genes. ] 
Invest DermatoI101:514-516, 1993 
nucleotides between rearranging sequences [7 - 9] . When DNA 
from polyclonal lymphoid cells is amplified and analyzed by gel 
electrophoresis, only a smear is visible, representing junctional re-
gions of rearranged TCR-genes of numerous different sizes. How-
ever, when DNA from a clinical specimen with a monoclonal infil-
trate of lymphoid cells is analyzed, a distinct band is visible, 
representing the junctional region of rearranged TCR-gamma 
genes of the dominant cell population. Although these PCR-based 
assays, as described so far, can indicate the presence of a monoclonal 
subpopulation, interpretation of the data is not always possible un-
ambiguously, as lymphoid populations are detected based on size 
discrimination of the PCR products alone. Furthermore, these 
assays do not lead to a molecular characterization of the specific 
monoclonal lymphoid population of the malignant lymphoma of a 
particular patient. Thus, unlike Southern blot analyses of lympho-
mas, where a clone-specific band pattern is identified by hybridiza-
tion procedures, these PCR-based assays will not allow the compar-
ison of lymphoid clones in biopsies from different sites of a patient 
or taken at different time points during the course of the disease. 
Studies on the clonal evolution of lymphomas cannot be performed 
and the emergence of a second malignant clone in a patient will 
easily remain undetected. A recently developed technique~ [10] in-
volves the PCR amplification of rearranged TCR-gamma genes 
followed by fractionation of the PCR products by denaturing gra-
dient gel electrophoresis (DGGE). With this type of gel e1ectro-
'Wood GS, Liao S, Carol F, Crooks CF, Sklar J: Cutaneous lymphoid 
infiltrates: analysis by polymerase chain reaction and denaturing gradient gel 
electrophoresis (PCR/DGGE) (abstr) . ] [livest Derma/of 98:553, 1992. 
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phoresis PCR products are separated based on their size and nucleo-
tide sequence. Monoclonal lymphoid populations resu lt in one or 
more discrete bands in the gel and have been detected reproducibly 
by this technique. 
We herein describe a novel methodology that detects clonal 
lymphoid subpopu lations in clinical specimens by analysis of PCR 
products based on their nucleotide sequence. This technique leads to 
the identification of a specific band pattern upon polyacrylamide gel 
e lectrophoresis (PAGE), which is characteris tic for the clonal tumor 
cell population. This assay is based on the principle that the confor-
mational polymorphisms of RNA molecules strictly depend on the 
nucleotide sequence of the individual molecule. Upon non-dena-
turing PAGE, RNA molecules, which can assume elaborate second-
ary and tertiary structures, separate into severa l metastable confor-
mational forms. We and others recently found that even single base 
pair mutations change the distribution and the number of these 
forms, which are characteristic for the particular nucleotide se-
quence of the RNA molecule [11 ,12]. In the present study, highly 
variable junctional sequences of rearranged TCR-gamma genes are 
amplified by PCR using primers that bind to conserved regions of 
variable and joint segments of the gene. Subsequently, transcription 
of the PCR products into complementary RNA (cRNA) is easily 
accomplished with the use of a T7 polymerase promoter sequence 
added to the 5' end of one of the PCR primers. In clinical samples 
with a monoclonal lymphoid subpopulation, the cRNA molecules 
yield a clone-specific pattern upon non-denaturing PAGE. This 
pattern represents conformational polymorphisms of cRNA mole-
cules of rearranged TCR-gamma genes of the predominant lymph-
oid clone. 
MATERIALS AND METHODS 
Clinical Samples Eight formalin-fixed, paraffin-embedded skin biopsies 
from five patients with mycosis fungoides (MF) were studied. One patient 
had three biopsies taken from different sites of the body over 3 years. From 
another patient two biopsies had been taken over 2 years. In addition, a 
biopsy from a patient with a T-cell pseudolymphoma was obtained. Each 
biopsy had a size of approximately 1 X 1 cm. Seven adjacent 15-,uM - thick 
sections were cut from each paraffin block and placed into a 1.65-ml micro-
centrifuge tube. DNA was extracted as described [13,14]. Briefly, 1 ml of 
xylene was added to dissolve the paraffin. The pellet was washed once with 
100% ethanol and twice with 70% ethanol and resuspended in 100,ul of 
digestion buffer (0.2 M Tris-HCI, pH 8; 10 mM cthylenediaminctetraacetic 
acid, 1 % sodiumdodecylsu lfate) to which Proteinase K was added to a final 
concentration of 0.5 mgjml. After 24 h incubation at 55·C, the DNA was 
phenol-ch loroform extracted and ethanol precipitated. After washing twice 
with 70% ethanol, the pellet was resuspcnded in 100,ul of filtered and 
autoclaved water. Three,ul of each sample wcre used as template for PCR 
amplification reactions. Preparation and analysis of samples were performed 
in a blinded fashion without knowing which biopsies were taken from 
which patients. 
In Vitro DNA Amplification Reactions Highly variable junctional re-
gions of rearranged TCR-gamma genes were amplified by PCR using con-
sensus oligonucleotide primers annealing to conserved regions within the 
variable group I genes (primer VarieD''') and to conserved sequences ofTCR-
gamma joint 1 and 2 genes (primer JointeD''') [7,15]. A T7 RNA polymerase 
promoter sequence was added to the 5' end of primer VarieD"" Primer se-
quences were primer VarieD'''' T AA T AC GAC TCA CT A TAG GGA GCC 
AGG GTT GTG TTG GAA TCA (T7 RNA polymerase promoter se-
quence underlined) [16]; primer JointeD"" GAC AAC AAG TGTTGTTCC 
AC. PCR amplification reactions consisted of 2.5 U Taq DNA polymerase 
(Perkin Elmer Cetus), 25 pmol of each primer, 200,uM of each dNTP, 3,ul 
of the DNA solution of each sample, and a 1 X reaction buffer as supplied by 
the manufacturer in a volume of 50 ,ul overlaid with mineral oil. Amplifica-
tion conditions in a Perkin Elmer Cetus "Thermal Cycler" were 45 cycles of 
94 0 for 1 min, 55· for 30 seconds, 72 · for 30 seconds. 
Transcription of the peR Products into cRNA After PCR, 15 tll of 
the reaction mixture were added to 2.5,u1 of a lO X transcription buffer 
(400 mM Tris/HCI, pH 8.0, 120 mM MgCI2' 100 mM dithiothreitol, 
10 mM spermidine), 2.5,u1 of a 10 mM solution of ribonucleotides (ATP, 
CTP, GTP, UTP), 0.25,u1 of RNAsin (Promega, WI), 0.6 tll ofT7 RNA 
polymerase (69 U IIl I, Pharmacia, Piscataway, NJ), and DEPC treated water 
[0 a final volume of 25 Ill. 0.5 tll of 35S adenosine rriphosphate (1494 
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Fi~ure 1. Analy.sis of conformational polymorph isms of cRNA molecules 
~f JunctIOnal regiOns of rearranged TCR-gamma genes from eight fonna-
1111~fixed, paraffin-cmbedded skin biopsies of patiems with mycosis fun-
gOldes (MF) (samples 2 -~) and a patient with a T-cell pseudo lymphoma 
(sample 1). JUllctlOnal regIOns of rearranged TCR-gamma genes were am-
pltfied by PCR, transcnbed 111tO cRNA and analyzcd by non-denaturing 
PAGE. ' 
Ci/mmol) was added and the mixture was incubated for 1 h at 37 · C. To 
111actlvate the enzyme, 0.75 ,ul of 0.5 Methylenediaminetetraacetic acid was 
added. 
Gel Electrophoresis After the transcription reaction, 14 pI of rhe mix-
ture was added to a new tube containing 3.5,u1 of a loading buffer (50% 
glycerol, 0.25% bromphenolblue). After hcating to 65 · C for 7 min, the 
mIxture was loaded onto an 8% polyacrylamide gel (acrylamide/bisacry l-
amide 19: 1) cont3Jl1ll1g 10% glycerol and electrophoresed at 16·C in 1 X 
TBE buffer fo~ 3-4 hours at constant wattage (25W). After electrophoresis, 
the gel was dned and exposed to a Kodak XAR5 film overnight. 
RESULTS 
Analysis of cRNA molecul es of junctional regions of rearranged 
TCR-gamma genes of all samples from patients with MF revealed 
several dlstll1ct bands upon PAGE (Fig 1, samples 2 - 9). These 
bands repr~sent conformatIOnal polymorphisms of cRNA of the 
PC~-ampltfied JunctIOnal region ofTCR-gamma genes of the pre-
domll1ant lymphOid clone. In addition, a background smear is visi-
ble,. represent1l1g conformational polymorph isms of junctional 
regIOns of rearranged TCR-gamma genes of polyclonal T lympho-
cytes present 111 the leSion. When the pattern of bands visible on 
~AG~ was compared between samples, samples 3, 4, and 7 were 
Identical ; samples 8 and 9 also revealed an identical pattern. Com-
panson of these results to the clinica l data disclosed that samples 3, 
4, and 7 were bIOpSies from the same patient taken within a time 
perIod of 3 years. Samples 8 and 9 were biopsies from another 
1I1dlvldual patient taken at a time interval of 2 years. Samples 2, 5, 
a.nd 6, which sho~ed different band patterns on PAGE, were biop-
sies fro.m three dIfferent patients with MF. Sample 1, with no 
clearly Identifiable band pattern, was a biopsy from a patient with a ! -cell pscudolymphoma. Only a broad smear is visible, represent-
1I1g conformatIOnal polymorphisms of numerous different cRNA 
mo~ecules. Similar smears with accentuations at nearly identical 
posmons on the gel were observed, when other samples with a 
polyclonal lymphoid infiltrate, e.g., skin biopsies from patients 
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with lupus erythematosus or DNA from peripheral blood lympho-
cytes of healthy volunteers, were analyzed (data not shown). 
DISCUSSION 
The analysis of conformational polymorphisms of cRNA molecules 
of junctional regions of rearranged TCR-gamma genes is suitable 
for the molecular detection and characterization of monoclonal 
lymphoid populations in clinical specimens and provides a more 
rapid and convenient alternative to conventional Southern blot 
analyses. This novel approach is of special use for the dermatologist, 
as also small clinical samples , e.g., small skin biopsies as well as 
sections from formalin-fixed, paraffin-embedded tissues can be ana-
lyzed, which both frequently do not yield enough DNA for tradi-
tional Southern blot analyses. In addition, the assay can be per-
formed without radioactiviry, because a band pattern on PAGE can 
be visualized by ethidium bromide staining (data not shown). 
In the present study we extend and further develop our concept of 
using rearranged TCR-gamma genes for the molecular analysis of 
lymphomas. Previously [15]' a molecular marker sequence for the 
lymphoma of an individual patient was determined by subcloning 
ofPCR-amplifiedjunctional sequences of rearranged TCR-gamma 
genes into bacteria and subsequent sequence analysis of individual 
clones. In the present study, monoclonal lymphoid subpopulations 
in formalin-fixed, paraffin-embedded lymphoma specimens of in-
dividual patients are characterized solely based on a PCR amplifica-
tion reaction, transcription into cRNA, and gel electrophoresis. 
The cRNA conformational polymorphisms of highly variable 
rearranged genes represent a unique molecular "fingerprint" for 
individuallym.phocytic clones and allow the comparison of biopsies 
from different sites of the body, as well as biopsies taken at different 
time points of the disease. The cRNA conformational polymor-
phism> result in considerably more bands, upon non-denaturing 
PAGE (usually 5-10 bands) than analysis of PCR products by 
DGGE or analysis of genomic DNA by Southern blot techniques. 
This may be of advantage, as the molecular "fingerprint" provided 
by the cRNA based assay might be even more sensitive to nucleotide 
sequence differences in the amplified gene segment resulting in a 
change of the position of individual bands upon PAGE. 
When analyzing a clinical sample based on cRNA conforma-
tional polymorphisms the possibiliry that the pattern of bands ob-
served might represent polymorphisms of more than pne lymphoid 
clone cannot be excluded entirely. In these cases, initial analyses of 
the PCR products (prior to transcription into cRNA) by PAGE are 
likely to indicate a possible biallelic rearrangement or a biclonal 
lymphoid population by resulting in several distinct bands upon 
PAGE. However, even in cases where the pattern of bands of cRNA 
conformational polymorphisms represents more than one rear-
rangement, the emerge of an additional clone is likely to become 
obvious when the pattern of bands between samples (e.g., of an 
individual patient) are compared. 
Frequently, in patients with aT -cell lymphoma of the skin, en-
larged lymph nodes or cutaneous lesions, which develop during the 
long course of the disease, are difficult to classify . Using this assay, a 
proliferation of the respective malignant lymphoid clone of the 
lymphoma of the patient can be identified. Furthermore, this assay 
will allow studies of the clonal evolution of Iymphoproliferative 
disorders. For example, considerable controversy surrounds ques-
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tions about the clonal evolution of lymphomas in patients with 
pre-existing lymphomatoid papulosis. It is still unclear whether 
clonal lymphoid cells of a malignant lymphoma in patients with 
long-standing lymphomatoid papulosis derive from T-cell popula-
tions in pre-existing lesions of lymphomatoid papulosis. Recently, 
using time-consuming DNA sequence analyses, a clonal relation-
ship between lymphomatoid papulosis and Ki-l- positive large-cell 
anaplastic lymphoma has been shown [17], but larger studies using a 
more rapid technology, such as the present one, are needed. In 
addition, by analyzing junctional regions of rearranged immuno-
globulin genes, the novel approach presented in this study may also 
be applied to the molecular analysis of B-celilymphoid prolifera-
tions of the skin. 
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